An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
Clinical trial NCT05594992 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05594992
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2028-02-28
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.